𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines

✍ Scribed by Sartor, M; Steingrimsdottir, H; Elamin, F; Gäken, J; Warnakulasuriya, S; Partridge, M; Thakker, N; Johnson, N W

Book ID
110002308
Publisher
Nature Publishing Group
Year
1999
Tongue
English
Weight
150 KB
Volume
80
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

p53, p16 and cyclin D1: Molecular determ
p53, p16 and cyclin D1: Molecular determinants of radiotherapy treatment response in oral carcinoma
✍ R. Jayasurya; Geo Francis; S. Kannan; K. Lekshminarayanan; K.R. Nalinakumari; Th 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 98 KB

## Abstract Management of oral cancer by radiotherapy has witnessed promising advances in the past few years, with patient‐tailored radio fractionation regimens. Different fractionation schedules, conventional and altered regimes, have been used in curative radiotherapy. Although contribution of bi

Molecular analysis of the cyclin-depende
Molecular analysis of the cyclin-dependent kinase inhibitor genes p15INK4b/MTS21, p16INK4/MTS1, p18 and pl9 in human cancer cell lines
✍ Akihiko Gemma; Seiichi Takenoshita; Koichi Hagiwara; Aikou Okamoto; Elisa A. Spi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 660 KB

Cyclin-dependent kinillre-4 inhibitor genes (INK4) regulate the cell cycle and are candidate tumor-suppressor genes. To determine if alterations in the coding regions of the p18 and p l 9 genes, which are novel members of the INK4 family and if they correlate with the development of human cancer, 10

Fluorescence in situ hybridization for d
Fluorescence in situ hybridization for detecting genomic alterations of cyclin D1 and p16 in oral squamous cell carcinomas
✍ Narikazu Uzawa; Itaru Sonoda; Kunihiro Myo; Ken-Ichiro Takahashi; Ryozo Miyamoto 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB

## Abstract ## BACKGROUND Cyclin D1 (__CCND1__) and __p16__ alterations have been detected in oral squamous cell carcinomas (SCCs), suggesting that abnormalities of these genes may play an important role in the genesis or progression of oral SCCs and serve as independent prognostic indicators. The

Deletional, mutational, and methylation
Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer
✍ David F. Jarrard; G. Steven Bova; Charles M. Ewing; Sokhom S. Pin; Son H. Nguyen 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

The tumor suppressor gene CDKN2 (p16/MTS1) resides on chromosome 9p21 and encodes a 16 kDa inhibitor of the cyclin-dependent kinases. Inactivation of CDKN2 by homozygous deletion, point mutation, and recently described aberrant methylation in the 5' promoter region may increase progression through t